M. De Backer

A 12-week treatment for dermatophyte toe onychomycosis terbinafine 250mg/day vs. itraconazole 200mg/day-a double-blind comparative trial

M. De Backer, P de Keyser, C De Vroey et al. · British Journal of Dermatology · 1996 · 126 citations

Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: A double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day

M. De Backer, C De Vroey, Emmanuel Lesaffre et al. · Journal of the American Academy of Dermatology · 1998 · 112 citations

Continuous Oral Therapy, Twelve Weeks, Clinical Dermatology +4

Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study

P de Keyser, M. De Backer, D. Massart et al. · British Journal of Dermatology · 1994 · 54 citations

Lacosamide monotherapy in clinical practice: A retrospective chart review

Vicente Villanueva, Beatriz G. Giráldez, Manuel Toledo et al. · Acta Neurologica Scandinavica · 2018 · 33 citations · Full text

Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy

Michel Baulac, William Byrnes, Paulette Williams et al. · Acta Neurologica Scandinavica · 2016 · 15 citations · Full text